Pharmacotherapy for Essential Hypertension: A Brief Review
Hypertension is one of the leading causes of disability-adjusted life years and mortality, with approximately 15% prevalence worldwide. Most patients with hypertension from low- to high-income countries do not receive treatment. Among those who receive treatment, the majority remain undertreated and...
Saved in:
| Main Authors: | Behnam Heidari, Eleonora Avenatti, Khurram Nasir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2022-12-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1175 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An update of medical care in Marfan syndrome
by: Hsin-Hui Chiu
Published: (2022-01-01) -
Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy
by: Mahdi S. Agha, et al.
Published: (2025-07-01) -
Efficacy of angiotensin receptor blockers for erectile dysfunction in hypertensive men: A systematic review
by: Swati Sucharita Dash, et al.
Published: (2024-01-01) -
Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?
by: James A. Ker
Published: (2015-05-01) -
INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
by: S. V. Stolov
Published: (2020-12-01)